Cost-effectiveness of widespread screening for Chlamydia trachomatis

REFERENCES

• VAN HULST M, DE WOLF JTM, STAGINNUS U, RUITENBERG EJ, POSTMA MJ: Pharmaco-economics of blood transfusion safety; reviewing the available evidence. Vox Sang (2002) 83(2):146–155.
   PubMed Web of Science ®Google Scholar
• ADES AE, RADCLIFFE J, GIBB DM, SCULPHER MJ: Economic issues in the prevention of vertical transmission of HIV. Pharinacoeconoinics (2000)18:9–22.
   PubMed Web of Science ®Google Scholar
• POSTMA MJ, BECK EJ, MANDALIA S et al.: Universal HIV screening of pregnant women in England: cost effectiveness analysis. Br. Med. J. (1999)318:1656–1660.
   PubMed Web of Science ®Google Scholar
• BINDELS PJE, POSTMA MJ, PEERBOOMS PGH, COUTINHO RA, VAN DEN HOEK JAR: The positive effect of serological screening for syphilis during pregnancy in Amsterdam in the period 1985 — 1989. Nederlands Thdschrift voor Geneeskunde (1991)135:1319–1322.
   PubMedGoogle Scholar
• DWYER MJ, MCINTYRE PG: Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area. Epideiniol Infect (1996)117:121–131.
   PubMed Web of Science ®Google Scholar
• Bundesauschuss der Arzte und Krankenkassen. Mutterschaftsrichtlinien. Bundesanzeiger (1996) 37.
   Google Scholar
• HERMANN B, EGGER M: Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985 — 1993: declining rates for how much longer? Sex. Transin. Dis. (1995)22:253–260.
   PubMed Web of Science ®Google Scholar
• WALSH C, ANDERSON LA, IRWIN K: The silent epidemic of Chlamydia trachomatis: the urgent need for detection and treatment in women. J. Womens Health Gend. Based (2000)9:339–343.
   PubMedGoogle Scholar
• ANDERSON PM, MAY PM: Infectious diseases of humans; dynamics and control Oxford University Press, New York, NY, USA (1991).
   Google Scholar
• POSTMA MJ, WELTE R, VAN DEN HOEK JAR et al.: Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis. Health Econ. Prevention Care (2000)1:103–110.
   Google Scholar
• STAMM WE, GUINAN ME, JOHNSON C, STARCHER T, HOLMES KK, MCCORMACK WM: Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. New Engl. I Med. (1984)310:545–549.
   PubMed Web of Science ®Google Scholar
• SCHOLES D, STERGACHIS A, HEIDRICH FE, ANDRILLA H, HOLMS KK, STAMM WE: Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. New Engl. Med. (1996) 334:1362–1366.
   PubMed Web of Science ®Google Scholar
• WESTROM L, JOESEOF R, REYNOLDS G, HAGDU A, THOMPSON SE: Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex. Transm. Dis. (1992) 19:185–191.
   Google Scholar
• EGGER M, LOW N, SMITH GD, LINDBLOM B, HERMAN B: Screening for chlamydial infections and the risk of ectopic pregancy in a county of Sweden: ecological analysis. Br. Med. J. (1998) 316:1776–1780.
   PubMed Web of Science ®Google Scholar
• KAMWENDO F, FORSLIN F, BODIN L, DANIELSSON D: Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex. Transm. Dis. (1996) 23:384–391.
   Google Scholar
• KAMWENDO F, FORSLIN F, BODIN L, DANIELSSON D: Programmes to reduce pelvic inflammatory disease - the Swedish experience. Lancet (1998) 351(Suppl. III):25–28.
   Google Scholar
• SCHACHTER J, GROSSMAN M, SWEET RL, HOLT J, JORDAN C, BISHOP E: Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA (1986) 255:3374–3377.
   PubMed Web of Science ®Google Scholar
• SCHACHTER J, SWEET RL, GROSSMAN M, LANDERS D, ROBBIE M, BISHOP E: Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl. J. Med. (1986) 314:276–279.
   PubMed Web of Science ®Google Scholar
• RYAN Jr GM, ABDELLA TN, MCNEELEY SG, BASELSKI VS, DRUMMOND DE: Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am. J. °Intel Gynecol (1990) 162:34–39.
   PubMed Web of Science ®Google Scholar
• SCHACHTER J, GROSSMAN M: Chlamydial infections. Ann. Rev. Med. (1981) 32:45–61.
   PubMed Web of Science ®Google Scholar
• SMITH JR, TAYLOR-ROBINSON D: Infection due to Chlamydia trachomatisin pregnancy and the newborn. Baillieres Clin. Obster Gynaecol (1993) 7:237–255.
   PubMedGoogle Scholar
• MANGIONE-SMITH R, O'LEARY J, MCGLYNN EA: Health and cost-benefits of Chlamydia screening in young women. Sex. Transm. Dis. (1999) 26:309–316.
   PubMed Web of Science ®Google Scholar
• WELTE R, JAGER JC, POSTMA MJ: Cost-effectiveness of screening for genital Chlamydia trachomatis. Expert Rev Pharmacoeconom. Outcomes Res. (2001) 2:145–156.
   Google Scholar
• MORRE. SA, VAN VALKENGOED IGM, MOES RIVI et al.: Determination of the Chlamydia trachomatis prevalence in an asymptomatic screening population; performance of LCx and COBAS amplicor in urine specimens. Chit. Microbiol (1999) 37:3092–3096.
   Google Scholar
• KACENA KA, QUINN SB, HOWELL MR, MADICO GE, QUINN TC, GAYDOS CA: Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. Chit. Microbiol (1998) 36:481–485.
   Web of Science ®Google Scholar
• MORRE. SA, MEIJER CJLM, MUNK C et al.: Pooling of urine specimens for the detection of Chlarnydia trachomatis by PCR in a low prevalence population: cost saving strategy for epidemiological studies and screening programs. J. Chit. Microbiol (2000) 38:1679–1680.
   Google Scholar
• PEELING RW, TOYE B, JESSAMINE I, GEMMILL I: Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex. Transm. Inf. (1998) 74:66–70.
   PubMed Web of Science ®Google Scholar
• MORRE. SA, WELTE R, POSTMA MJ.: Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing. Sex. Transm. Inf. (2002) 78:74–75.
   PubMed Web of Science ®Google Scholar
• GENQ M, MARDH PA: Cost-effective treatment of uncomplicated gonorrhea including co-infection with Chlamydia trachomatis. Pharmacoeconom. (1997) 12:374–383.
   PubMed Web of Science ®Google Scholar
• TURRENTINE MA, NEWTON ER. Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obst. Gynecol (1995) 86:1021–1025.
   PubMed Web of Science ®Google Scholar
• WEHBEH HA, RUGGEIRIO RM, SHAHEM S, LOPEZ G, ALI Y: Sinle-dose azithromycin for Chlamydia in pregnant women. J. Reprod. Med. (1998) 43:509–514.
   PubMed Web of Science ®Google Scholar
• BOS JM, FENNEMA JSA, POSTMA MJ: Cost-effectiveness of HIV screening of patients attending clinics for sexually transmitted diseases in Amsterdam. AIDS (2001) 15:2031–2078.
   PubMed Web of Science ®Google Scholar
• SOMANI J, BHULLAR VB, WORKOWSKI KA, FARSHY CE, BLACK CM: Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. (2000) 181:1421–1427.
   PubMed Web of Science ®Google Scholar
• STEPHENS RS, KALMAN S, LAMMEL C et al.: Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis Science (1998) 282:754–759.
   Google Scholar
• VAN DEN HOEK JAR, MULDER-FOLKERTS DDF, COUTINHO RA, DUKERS NHTM, BUIMER M, VAN DOORNUM GJJ: Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam (in Dutch). Ned. Thrlschr: Geneeskd. (1999) 143:668–672.
   PubMedGoogle Scholar
• NYARI T, NYARI C, WOODWARD M, MESZAROS G, DEAK J, NAGY E, KOVACS L: Screening for Chlamydia trachomatis in asymptomatic women in Hungary; an epidemiological and cost-effectiveness analysis. Acta Obstet. Gynecol Scand. (2001) 80:300–306.
   PubMed Web of Science ®Google Scholar
• GENg M, MARDH PA: A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann. Intern. Med. (1996) 124:1–7.
   PubMed Web of Science ®Google Scholar
• HOWELL MR, MCKEE KT, GAYDOS JC, QUINN TC, GAYDOS CA. Point-of-entry screening for C. trachomatis in female army recruits; who deserves the cost savings? Am. J. Prey Med. (2000) 19:160–166.
   Google Scholar
• VAN VALKENGOED IGM, POSTMA MJ, MORRE. SA, et al:. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex. Transm. Inf. (2001) 77:276–282.
   Google Scholar
• POSTMA MJ, BAKKER A, WELTE R, et al: Screening for asymptomatic infection with Chlamydia trachomatis in pregnancy; favourable cost-effectiveness at prevalences above 3% (in Dutch). Ned. Tijdschr. Geneeskd. (2000) 144:2350–2354.
   PubMedGoogle Scholar
• GOLD MR, SIEGEL JE, RUSSEL LB, WEINSTEIN MC: Cost-effectiveness in Health and Medicine. Oxford University Press, New York, NY, USA (1996).
   Google Scholar
• POSTMA MJ, WELTE R, VAN DEN HOEK JAR, MORRE. SA: Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches. Sex. Transm. Inf (2002) 78:73–74.
   Google Scholar
• QUIN TC, GAYDOS C, SHEPHERD M et al.: Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 276:1737–1742.
   PubMed Web of Science ®Google Scholar
• GENIC M, RUUSUVAARA L, MARDH P-A: An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA (1993) 17:2057–2064.
   Google Scholar
• POSTMA MJ, WELTE R, VAN DEN HOEK JAR, VAN DOORNUM GJJ, JAGER JC, COUTINHO RA: Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia trachcmatis Value in Health (2001) 4:266–275.
   Google Scholar
• KRETZSCHMAR M, WELTE R, VAN DEN HOEK JAR, POSTMA MJ: Comparative Model-based Analysis of Screening Programs for Chlarnydia trachcmatis Infections. Am. J. Epidemic] (2001) 153:90–101.
   PubMedGoogle Scholar
• WELTE R, KRETZSCHMAR M, LEIDL R, VAN DEN HOEK JAR, JAGER JC, POSTMA MJ: Cost-effectiveness of screening programs for Chlarnydia trachcmatis Sex. Transm. Dis (2000) 27:518–529.
   PubMedGoogle Scholar
• WELTE R, KRETZSCHMAR M, JAGER JC, LEIDL R, VAN DEN HOEK JAR, POSTMA MJ: Opportunistic screening for genital infection with Chlamydia trachcmatis among the sexually active population of Amsterdam. IV. Cost-effectiveness analysis of screening including the dynamics of the spread of an infectious disease in a population. Ned. Thrlschr. Geneeskd. (2002)
   Google Scholar